Creatine Monohydrate

Overview

Creatine is a naturally occurring nitrogenous compound synthesized in the liver, kidneys, and pancreas from the amino acids glycine, arginine, and methionine. About 95% of the body's creatine pool is stored in skeletal muscle as phosphocreatine; the remaining ~5% is distributed in the brain, heart, and other tissues. Daily creatine requirements (~1–3g) are met by a combination of endogenous synthesis and dietary intake from meat, fish, and dairy. Creatine monohydrate is the most extensively researched and cost-effective supplemental form, with hundreds of RCTs confirming its safety and ergogenic efficacy. More recently, a substantial body of cognitive research has established creatine as a legitimate nootropic — particularly in states of metabolic stress such as sleep deprivation, hypoxia, and vegetarianism, where baseline brain creatine stores are lower. The molecular data shown represents the monohydrate form, which is chemically identical to anhydrous creatine plus one water molecule of crystallization.

Mechanism of Action

In neurons and muscle cells, creatine is phosphorylated by creatine kinase to phosphocreatine (PCr), which serves as a rapidly mobilizable reservoir of high-energy phosphate bonds. When cellular ATP demand spikes, PCr donates its phosphate group to ADP, regenerating ATP on a sub-second timescale. This phosphocreatine–ATP shuttle is especially relevant in the brain under conditions of high cognitive load, metabolic stress, or sleep deprivation, where supplementation raises brain PCr concentrations by ~5–9% (measurable by ³¹P-MRS). Secondary mechanisms include reduced neuronal mitochondrial oxidative stress, modulation of glutamatergic and dopaminergic signaling, and membrane-stabilizing effects. The cognitive benefits are largest when baseline brain creatine is low (vegetarians, sleep-deprived individuals, older adults) and smaller — though still measurable — in rested, well-nourished omnivores.